Swiss All Share Index

Swiss All Share Index handeln
18.387,70 PKT +165,37 PKT +0,91 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
28.01.19 UBS overweight JP Morgan Chase & Co.
28.01.19 ABB (Asea Brown Boveri) Sell Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
25.01.19 Givaudan Neutral JP Morgan Chase & Co.
25.01.19 Holcim overweight JP Morgan Chase & Co.
25.01.19 Givaudan Neutral JP Morgan Chase & Co.
25.01.19 Givaudan buy Baader Bank
25.01.19 Givaudan Hold Kepler Cheuvreux
25.01.19 Givaudan Underweight Barclays Capital
25.01.19 UBS buy HSBC
25.01.19 Givaudan Underperform Bernstein Research
25.01.19 Givaudan Neutral UBS AG
25.01.19 Givaudan Sell Goldman Sachs Group Inc.
24.01.19 Swiss Re buy Goldman Sachs Group Inc.
24.01.19 UBS Hold Deutsche Bank AG
24.01.19 UBS Reduce Kepler Cheuvreux
24.01.19 Roche Conviction Buy Goldman Sachs Group Inc.
24.01.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
24.01.19 Nestlé buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
24.01.19 Holcim Sell UBS AG
23.01.19 Logitech Hold Maxim Group
23.01.19 Zurich Insurance Hold Deutsche Bank AG
23.01.19 Nestlé buy Deutsche Bank AG
23.01.19 UBS Sector Perform RBC Capital Markets
23.01.19 UBS overweight JP Morgan Chase & Co.
23.01.19 Swiss Re buy HSBC
23.01.19 Holcim overweight JP Morgan Chase & Co.
22.01.19 Swiss Re overweight JP Morgan Chase & Co.
22.01.19 UBS Neutral Goldman Sachs Group Inc.
22.01.19 UBS overweight Morgan Stanley
22.01.19 UBS buy Baader Bank
22.01.19 UBS Sector Perform RBC Capital Markets
22.01.19 UBS Underweight Barclays Capital
22.01.19 UBS Hold Deutsche Bank AG
21.01.19 Swiss Re Sector Perform RBC Capital Markets
21.01.19 UBS Neutral Goldman Sachs Group Inc.
21.01.19 UBS buy Goldman Sachs Group Inc.
18.01.19 UBS Outperform Credit Suisse Group
18.01.19 ams-OSRAM Neutral UBS AG
18.01.19 Novartis Neutral UBS AG
18.01.19 Roche overweight JP Morgan Chase & Co.